Tag | Content |
---|
EnhancerAtlas ID | HS073-13765 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr8:28185800-28186650 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nr2f6(var.2) | MA0728.1 | chr8:28185813-28185828 | TGAACTCCTGACCTC | - | 6.22 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_10187 | chr8:28185946-28187090 | CD19_Primary | SE_10881 | chr8:28185524-28187600 | CD20 | SE_58992 | chr8:28165452-28207351 | Ly3 | SE_59946 | chr8:28164768-28207284 | Ly4 | SE_61002 | chr8:28174118-28277761 | HBL1 | SE_63042 | chr8:28186067-28207603 | Tonsil | SE_65386 | chr8:28186232-28187391 | Pancreatic_islets |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 4 | Chromosome | Start | End |
chr8 | 28185985 | 28186042 | chr8 | 28186163 | 28186419 | chr8 | 28186101 | 28186200 | chr8 | 28186200 | 28186275 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH08I028328 | chr8 | 28185525 | 28187600 |
|
Enhancer Sequence | GCCAGGCTGG TCTTGAACTC CTGACCTCTA GTGATCCACC TGCCCTGGCC TCCCAAAGTT 60 CTGGGATTAC AGGCATGAGC CACTGTGCCT GGCCCAAAGA TCCCATCTCT TAATATCATC 120 ACGTTGGAGG TTAGGATTTC AACATAGGAA TTTTAGGGAG ACAGAGATAG ACCATAGCAC 180 TAGCTCACAT CTAACAGGGA TAAGAGGCAA GTACCTGGAA GAGAGAATTC GGGGTATGGG 240 GGGTTGGGGG CATTCCTGGC TGCAGCAGGG AAGGCCAGGA GGATGAAAGG AAGCATTTGA 300 GTCATTAATA AATGTCATAT TTTACTCATC TTACTTTTGC ACAGCACTTT GCAAAACTCC 360 CCTTACAGAT CTCATTTCAT CTTCACAATA GGCCTGTGAT AAGGCAGGTG CCACTGTTCC 420 CCTTTTATGG GCTATGAAAA CTGAGGCTCA AAGTGGTTGA TTTAATGTCA CATGCTGGTA 480 AACTGCAAAG CGATGCCTTT AGCTCCCAAG AAAGCTATCT CTGCCACCAC ACAGCTGCTC 540 CCAAAAGTGC CTATGAGGTG TCGAGGCCAG CCAGGTGGCA GGAATCACAG GGGTGTCCTG 600 CCACCCAGGA CTAACCCAGG AACCCAGACA CACTAACAAG CCTCTACATG AACACTGAGC 660 CTAGGTGATA GGCAGGGTCG CCTATGGCCT TGACAATTTA CACCCCTGCA AAGTGAATCA 720 CAGGCCCCTA GTGCCATCCT GCCAGAGACA GCAGAGAAGT GTCTTTCCTG CATTCTCTGG 780 GTTAGGTCTC TGGCCCTGAG CAGCCCTCCG AGAATGGCTG TACTCATTGC CATGCTTCCT 840 GTATGTTCCA 850
|